论文部分内容阅读
目的探讨无创正压通气(NIPPV)治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭的临床疗效。方法 50例NIPPV合并呼吸衰竭患者的血气分析变化,住院时间气管插管率和病死率,并同以往未使用无创治疗的30例AECOPD合并呼吸衰竭的病例进行比较。结果 50例NIPPV治疗后2 h,48 h的血气分析指标明显改善,住院时间明显短,于对照组,气管插管率,住院病死率明显低于对照组,两者比较差异具有统计学意义。结论 NIPPV治疗慢性阻塞性肺疾病(COPD)合并Ⅱ型呼吸衰竭疗效确切,避免机械通气,缩短病程,是救治COPD合并呼吸衰竭患者的一种有效方法。
Objective To investigate the clinical efficacy of noninvasive positive pressure ventilation (NIPPV) in the treatment of chronic obstructive pulmonary disease (COPD) with type Ⅱ respiratory failure. Methods Fifty patients with NIPPV combined with respiratory failure were analyzed for changes in blood gases, intubation and mortality during hospital stay, and compared with 30 cases of AECOPD complicated with respiratory failure which were not used before. Results 50 cases of NIPPV after 2 h, 48 h of blood gas analysis indicators improved significantly shorter hospital stay in the control group, tracheal intubation rate, hospital mortality was significantly lower than the control group, the difference between the two statistically significant. Conclusion NIPPV is effective in treating chronic obstructive pulmonary disease (COPD) complicated with type Ⅱ respiratory failure, avoiding mechanical ventilation and shortening the course of disease, and is an effective method for treating COPD with respiratory failure.